Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies.
Gunst JD, Gohil J, Li JZ, Bosch RJ, White Catherine Seamon A, Chun TW, Mothe B, Gittens K, Praiss L, De Scheerder MA, Vandekerckhove L, Escandón K, Thorkelson A, Schacker T, SenGupta D, Brander C, Papasavvas E, Montaner LJ, Martinez-Picado J, Calin R, Castagna A, Muccini C, de Jong W, Leal L, Garcia F, Gruters RA, Tipoe T, Frater J, Søgaard OS, Fidler S. Gunst JD, et al. Among authors: muccini c. Nat Commun. 2025 Jan 21;16(1):906. doi: 10.1038/s41467-025-56116-1. Nat Commun. 2025. PMID: 39837813
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry.
Clemente T, Diotallevi S, Minisci D, Di Biagio A, Lolatto R, Attala L, Cenderello G, Siribelli A, Muccini C, Lo Caputo S, Tavio M, Papaioannu Borjesson R, Giacomelli A, Castagna A, Spagnuolo V; PRESTIGIO Study Group. Clemente T, et al. Among authors: muccini c. J Antimicrob Chemother. 2024 Dec 27:dkae465. doi: 10.1093/jac/dkae465. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 39727173
DoxyPEP: real-life effectiveness in a cohort of men who have sex with men in Milan, Italy.
Raccagni AR, Diotallevi S, Lolatto R, Bruzzesi E, Catalano G, Mainardi I, Maci C, Candela C, Muccini C, Castagna A, Nozza S. Raccagni AR, et al. Among authors: muccini c. Lancet Infect Dis. 2025 Jan;25(1):e1-e3. doi: 10.1016/S1473-3099(24)00726-6. Epub 2024 Nov 19. Lancet Infect Dis. 2025. PMID: 39577454 No abstract available.
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting.
Papaioannu Borjesson R, Clemente T, Diotallevi S, Lolatto R, Forniti A, Bottanelli M, Galli L, Gianotti N, Muccini C, Hasson H, Castagna A, Spagnuolo V. Papaioannu Borjesson R, et al. Among authors: muccini c. J Antimicrob Chemother. 2024 Nov 21:dkae420. doi: 10.1093/jac/dkae420. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 39568118
In depth analysis of the HIV reservoir confirms effectiveness and safety of DTG/3TC in a phase 4 randomized controlled switch trial (RUMBA).
De Scheerder MA, Degroote S, Delporte M, Kiselinova M, Trypsteen W, Vincke L, De Smet E, Van Den Eeckhout B, Schrooyen L, Verschoore M, Muccini C, Vanherrewege S, Caluwe E, De Buyser S, Gerlo S, Blomme E, Vandekerckhove L. De Scheerder MA, et al. Among authors: muccini c. J Infect Dis. 2024 Sep 3:jiae405. doi: 10.1093/infdis/jiae405. Online ahead of print. J Infect Dis. 2024. PMID: 39226296
68 results